Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis

[1]  M. Oda,et al.  Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. , 1999, The Annals of thoracic surgery.

[2]  T. Sawada,et al.  Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma , 1999, Cancer.

[3]  B. Smoller,et al.  Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  K. Yasumoto,et al.  Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. , 1998, The Journal of thoracic and cardiovascular surgery.

[5]  K. Eguchi,et al.  Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. , 1998, Anticancer research.

[6]  L. Ellis,et al.  Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. , 1998, European journal of cancer.

[7]  P. Heikkilä,et al.  Enhanced expression of vascular endothelial growth factor in metastatic melanoma. , 1997, British Journal of Cancer.

[8]  O. Vinante,et al.  Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. , 1997, Journal of the National Cancer Institute.

[9]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[10]  H. Wada,et al.  Time trends and survival after operations for primary lung cancer from 1976 through 1990. , 1996, The Journal of thoracic and cardiovascular surgery.

[11]  J. Niloff,et al.  Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[12]  I. Ellis,et al.  Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? , 1995, Human pathology.

[13]  J. Roth,et al.  Survival in early-stage non-small cell lung cancer. , 1995, The Annals of thoracic surgery.

[14]  N. Weidner.  Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[15]  M. Volm,et al.  Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. , 1995, International journal of oncology.

[16]  M. Toi,et al.  Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer , 1994, Japanese journal of cancer research : Gann.

[17]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[18]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[19]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[20]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[21]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[22]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[23]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[25]  R. Vallance,et al.  Neoplasms of the lung. , 1978, British medical journal.

[26]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[27]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[28]  友田 政昭.  Intratumoral neovascularization and growth pattern in early gastric carcinoma , 2001 .

[29]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[30]  Y. Tomita,et al.  Angiogenesis in malignant fibrous histiocytoma. , 1995, Oncology.

[31]  山崎 浩一.  Tumor angiogenesis in human lung adenocarcinoma , 1995 .

[32]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[33]  [Histological typing of lung tumors. Second edition, 1981 (author's transl)]. , 1981, Annales de pathologie.